Ultrasensitive chemiluminescence assay for cimetidine detection based on the synergistic improving effect of Au nanoclusters and graphene quantum dots
- 5 February 2019
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 34 (2) , 261-271
Abstract
A novel and sensitive chemiluminescence (CL) procedure based on the synergetic catalytic effects of gold nanoclusters (Au NCs) and graphene quantum dots (GQDs) was developed for the reliable measurement of cimetidine (CM). The initial experiments showed that the KMnO4‐based oxidation of alkaline rhodamine B (RhoB) generated a very weak CL emission, which was intensively enhanced in the simultaneous presence of Au NCs and GQDs. CL intermediates can be adsorbed and gathered on the surface of Au NCs, becoming more stable. GQDs participate in the energy transferring processes and facilitate them. These improving effects were simultaneously obtained by adding both Au NCs and GQDs into the RhoB‐KMnO4 reaction. Consequently, the increasing effect of the Au NCs/GQDs mixture was more than that of pure Au NCs or GQDs, and a new nano‐assisted powerful CL system was achieved. Furthermore, a marked quenching in the emission of the introduced CL system was observed in the presence of CM, so the system was examined to design a sensitive sensor for CM. After optimization of influencing parameters, the linear lessening in CL emission intensity of KMnO4‐RhoB‐Au NCs/GQDs was verified for CM concentrations in the range 0.8–200 ng ml−1. The limit of detection (3Sb/m) was 0.3 ng ml−1. Despite being a simple CL method, good sensitivity was obtained for CM detection with reliable results for CM determination in human urine samples.Keywords
This publication has 49 references indexed in Scilit:
- Use of a monolithic column for the development and validation of a HPLC method for the determination of famotidine, cimetidine and nizatidine in biological fluidsJournal of Applied Bioanalysis, 2017
- Determination of histamine H2 receptor antagonists in pharmaceutical formulations by CE-MSAnalytical Methods, 2014
- Comparative validations of non-aqueous capillary electrophoresis and high-performance liquid chromatography methods for the simultaneous determination of histamine H2 receptor antagonists in human urineJournal of Chromatography B, 2013
- GC Determination of Famotidine, Ranitidine, Cimetidine, and Metformin in Pharmaceutical Preparations and Serum Using Methylglyoxal as Derivatizing ReagentChromatographia, 2012
- Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: Application to the analysis of ranitidine and its metabolites in human volunteersJournal of Chromatography B, 2007
- Convenient and rapid determination of cimetidine in human plasma using perchloric acid‐mediated plasma protein precipitation and high‐performance liquid chromatographyBiomedical Chromatography, 2007
- Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cimetidine**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.Journal of Pharmaceutical Sciences, 2006
- Evaluation of P‐glycoprotein—Mediated Renal Drug Interactions in an MDR1‐MDCK ModelPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Determination of cimetidine in human plasma by use of coupled-flow injection, solid-phase extraction, and capillary zone electrophoresisChromatographia, 2001
- Determination of cimetidine in pure form and in dosage forms using N,N-dibromodimethylhydantoinThe Analyst, 1994